Home › Funds › SHENKMAN CAPITAL MANAGEMENT INC › RGEN

SHENKMAN CAPITAL MANAGEMENT INC position in RGEN

Repligen Corp · Health Care

SHENKMAN CAPITAL MANAGEMENT INC reported holding 5,183,000 shares of RGEN (Repligen Corp) in its Q3 2026 13F filing — a position valued at US$6.2M, representing 1.26% of its reported portfolio and ranking #22 among its reported holdings. SHENKMAN CAPITAL MANAGEMENT INC has disclosed RGEN holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)5.18M sh
Reported value held$6.21M
Portfolio Weight1.26%
First reportedQ4 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SHENKMAN CAPITAL MANAGEMENT INC's RGEN position evolved

SHENKMAN CAPITAL MANAGEMENT INC first disclosed a stake in RGEN in Q4 2024 at 4,199,000 shares (US$4.4M). The position peaked in Q2 2026 at 12,478,000 shares, worth US$13.0M. Across 8 filings, SHENKMAN CAPITAL MANAGEMENT INC increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,183,000 shares valued at US$6.2M — a reduction of -7,295,000 shares quarter over quarter.. Notable position changes include a 95% increase in Q1 2025 (shares fell 2% over the following quarter), a 58% trim in Q3 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 4.20M $4.44M New
Q1 2025 8.18M $8.31M Add
Q2 2025 8.88M $8.90M Add
Q3 2025 9.47M $9.75M Add
Q4 2025 10.11M $11.32M Add
Q1 2026 11.36M $11.31M Add
Q2 2026 12.48M $13.05M Add
Q3 2026 5.18M $6.21M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (Repligen Corp) is a Health Care company. 33 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has SHENKMAN CAPITAL MANAGEMENT INC held RGEN?

SHENKMAN CAPITAL MANAGEMENT INC has disclosed RGEN holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is SHENKMAN CAPITAL MANAGEMENT INC's current position in RGEN?

As of Q3 2026, SHENKMAN CAPITAL MANAGEMENT INC holds 5.18M shares of RGEN (Repligen Corp), valued at $6.21M, representing 1.26% of its reported portfolio and ranking #22.

Has SHENKMAN CAPITAL MANAGEMENT INC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), SHENKMAN CAPITAL MANAGEMENT INC reduced its position in RGEN. The position peaked in Q2 2026 at 12.48M shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.